ライフサイエンスコーパス: splenic vein

1 n portal vein, superior mesenteric vein, and splenic vein.

2 he inferior mesenteric vein drained into the splenic vein.

3 on the confluence of the superior mesenteric/splenic veins.

4 aller structures showed lower DSC (portal or splenic veins: 0.64-0.78, adrenal glands: 0.56-0.69).

5 the coeliac trunk, superior mesenteric vein, splenic vein and portal vein (PV).

6 Puncture of the splenic vein and stent placement were successfully compl

7 binding potential, particularly between the splenic vein and the entrance of the liver.

8 ortal vein, splenic mesenteric junction, and splenic vein, causing an engorged inferior mesenteric ve

9 The mutation was detected in the splenic vein ECs of 1 of 6 patients investigated.

10 ced velocities in small arteries and reduced splenic vein flow.

11 othelial cells (ECs) from spleen tissues and splenic vein harbored this mutation.

12 tery, portal vein, superior mesenteric vein, splenic vein, hepatic veins, and inferior vena cava (IVC

13 ctronic calipers from the axial image at the splenic vein level after completion of the CT scan.

14 ortal and superior mesenteric veins (n = 7), splenic vein (n = 4), and aorta (n = 1).

15 Splenic vein occlusion is present in 7% of patients unde

16 ortal vein, splenic mesenteric junction, and splenic vein occlusions; hence, it should be kept in min

17 e evidence that some ECs from the spleen and splenic veins of patients with MF bear the JAK2V617F mut

18 inically unsuspected partial thrombus in the splenic vein on imaging.

19 e is <50% occlusion of the main portal vein, splenic vein, or mesenteric veins.

20 for splenic artery (P(interaction) = 0.43), splenic vein (P(interaction) = 0.30), retroperitoneal (P

21 Two other pigs died, one with aberrant splenic vein positioning near the GJA and the other from

22 control group, the MPV was visualized in 37; splenic vein (SV), in 37; superior mesenteric vein (SMV)

23 ained in the superior mesenteric vein (SMV), splenic vein (SV), portal vein (PV), and the TIPS.

24 g the portal vein (eight of eight patients), splenic vein (three of four patients), and superior mese

25 een grafts were lost from rejection (n=5) or splenic vein thrombosis (n=1), and five remained viable.

26 al imaging have led to the identification of splenic vein thrombosis in patients with minimal symptom

27 Although the outcome of splenic vein thrombosis in the absence of anticoagulatio

28 The outcome and management of isolated splenic vein thrombosis in the pancreas transplant is un

29 suggest that (1) in SPK, anticoagulation for splenic vein thrombosis maintains graft survival, and (2

30 variceal bleeding from pancreatitis-induced splenic vein thrombosis occurs in only 4% of patients; t

31 Previous studies have suggested that splenic vein thrombosis results in a high likelihood of

32 n does not alter the ultimate progression of splenic vein thrombosis to complete graft thrombosis.

33 atients with a diagnosis of pancreatitis and splenic vein thrombosis were identified.

34 was disseminated tuberculosis complicated by splenic vein thrombosis.

35 reatment led to a complete resolution of the splenic vein thrombosis.

36 ssociation with transplant failure than does splenic vein thrombus or edema.

37 Splenic vein thrombus was identified in 10 of 20 failed

38 of intraparenchymal forward diastole flow), splenic vein thrombus, and edema.

39 erior mesenteric vein (SMV) joining with the splenic vein to form the portal vein.

40 splenic venogram revealed good flow from the splenic vein to the left renal vein through the shunt tr

41 f large vessels, endothelial tissue from the splenic vein was also studied.

42 The splenic vein was opened distally at the tail of the panc

43 The proximal splenic vein was punctured transvenously through the ret

44 An increased calibre of the splenic vein with a hyperechogenicity within it raised t